You are now leaving the Lilly Medical Education website
The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical Education.
Disease Education Resources
Oncology
Explore our library of Lilly-created medical education resources. Please note: These resources do not offer CME/CE credit.
Non-Small Cell Lung Cancer
Exposing KRAS G12C: Not Your Usual Suspect in NSCLC
Educational overview of KRAS G12C as a unique oncogenic driver in NSCLC and its role in shaping targeted treatment strategies.
Implementing Biomarker-Informed Cancer Care in NSCLC
Walk through the treatment journey for stage IV NSCLC with key considerations to improve patient access to targeted therapies.
Minimizing Turnaround Time for Molecular Testing Among Patients With NSCLC
This video summarizes the infographic on barriers and solutions for minimizing turnaround time for molecular testing.
Progress in Molecular Education: Genomic Testing in Advanced NSCLC
Hear from experts on how to successfully implement upfront, broad, and timely molecular pathology in advanced or metastatic NSCLC.
Reducing QNS Rates for Molecular Testing Among Patients With NSCLC
This video summarizes the infographic on barriers and solutions for reducing QNS rates for molecular testing.
Treatment Roadmap for Targeted Therapies in NSCLC
Explore the Let's Talk About Targeted Therapies in NSCLC treatment roadmap, overview videos, and discussion guides for helpful resources.
Video: Biomarker Testing in Early-Stage Non-Small Cell Lung Cancer with Dr. Stewart Yang
In this video, Dr. Stewart Yang answers questions regarding biomarkers related to early-stage NSCLC. Click to learn more.
Video: Clinical Perspectives: Tailored Treatment Approaches for KRAS G12C– Mutant NSCLC
Clinical Perspectives: Tailored Treatment Approaches for KRAS G12C-Mutant NSCLC Video
Learn more about comprehensive biomarker testing in early-stage NSCLC.
An infographic on biomarker testing in early stage nsclc: Overcoming Barriers to Optimize Implementation
Infographic: Biomarker-Informed Treatment of Early-Stage NSCLC
This infographic provides an overview of comprehensive biomarker testing in early-stage NSCLC.
This infographic provides an overview of comprehensive biomarker testing opportunities in early-stage NSCLC.
This infographic provides an overview of how to implement comprehensive biomarker testing in early-stage NSCLC.
This infographic is intended to educate Health Care Providers on barriers and solutions for minimizing turnaround time for molecular testing.
This infographic is intended to educate Health Care Providers on barriers and solutions for reducing QNS rates for molecular testing.
This workmat outlines how patient and tissue navigators may be able to help solve and prevent challenges commonly faced during the molecular testing process in non-small cell lung cancer (NSCLC).
Patient Education Resources
Explore our library of patient based education materials to aid in HCP to patient interactions.